Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.89 USD
Change Today -0.03 / -1.03%
Volume 11.8K
ENZ On Other Exchanges
Symbol
Exchange
New York
Munich
As of 12:15 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Barry W. Weiner

Co-Founder, President, Chief Financial Officer, Principal Accounting Officer, Treasurer and Director,Enzo Biochem Inc.
AgeTotal Calculated CompensationThis person is connected to 4 board members in 1 different organizations across 3 different industries.

See Board Relationships
65$945,778
As of Fiscal Year 2014

Background*

Mr. Barry W. Weiner has been the President of Enzo Biochem Inc. at Enzo Life Sciences, Inc. since November 1996. Mr. Weiner co-founded Enzo Biochem Inc., holding company of Enzo Clinical Labs, Inc. and has been its President since November 1996. Mr. Weiner serves as the Chief Financial Officer and Principal Accounting Officer of Enzo Biochem Inc. and has been its Treasurer since November 25, 2009. He served as Executive Vice President of Enzo Biochem Inc., from September ...

Read Full Background

Corporate Headquarters*

527 Madison Avenue
New York, New York 10022

United States

Phone: 212-583-0100
Fax: --

Board Members Memberships*

1977-Present
Co-Founder, President, Chief Financial Officer, Principal Accounting Officer, Treasurer and Director

Education*

MBA
Boston University
Bachelor's Degree
New York University
BS
New York University

Other Affiliations*

Annual Compensation*

Salary$492,708
Total Annual Compensation$492,708

Stock Options*

All Other Compensation$153,233
Exercisable Options50,000
Unexercisable Options64,107
Total Number of Options114,107

Total Compensation*

Total Annual Cash Compensation$910,941
Total Short Term Compensation$492,708
Other Long Term Compensation$153,233
Total Calculated Compensation$945,778
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENZ:US $2.89 USD -0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William J. Welch M.B.A.Chief Executive Officer, President and Director
Sequenom Inc.
$433.0K
Raymond C. Kubacki Jr.Chairman, Chief Executive Officer and President
Psychemedics Corp.
$536.9K
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$735.3K
R. Bradley Gray Chief Executive Officer, President and Director
NanoString Technologies, Inc.
$441.8K
Michael W. Hunkapiller Ph.D.Executive Chairman, Chief Executive Officer and President
Pacific Biosciences of California, Inc.
$1.00
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENZO BIOCHEM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.